Previous work has demonstrated increased implant failure in patients with DDH compared to osteoarthritis with historic methods and implants. This study examines outcomes of modern total hip arthroplasty (THA) techniques using uncemented fixation and cross-linked PE (XLPE) bearings for DDH.

A consecutive series of 879 patients with DDH who underwent primary THA with uncemented components and a XLPE bearing at a single institution between 1999 and 2016 were identified. Mean age at index arthroplasty was 51 years, with 78% females. Mean follow-up was 8 years.

5- and 10-year survivorships free of revision were 98.4% and 98%, respectively. 5- and 10-year survivorships free of reoperation for any reason were 97% and 96%, respectively. Survivorship free of acetabular revision for aseptic loosening was 99.8% at 5 and 10 years, while survivorships free of femoral revision for aseptic loosening were 99.7% at 5 years and 99.5% at 10 years. Survivorship free of reoperation for PE damage (2 liner fractures, 2 rim damage from impingement) was 99.3% at 10 years. There were no revisions for bearing surface wear or osteolysis. 13% of patients experienced complications (4% dislocation, 3.3% wound complication rate). Ten-year survivorship free of reoperation for instability was 99.2%. 8 patients developed infection requiring operation (<1%). 100 patients had a prior pelvic osteotomy (11%), which did not increase rate of complications (p=0.22) or reoperations (p=0.51).

Fixation with modern uncemented implants has dramatically reduced implant loosening in patients with DDH, and the use of XLPE bearings has markedly reduced revision for PE wear/osteolysis in this young patient population, leading to dramatically improved mid/long-term survivorship compared to historic series.

Assess union rate, complications, and outcomes of large series of contemporary extended trochanteric osteotomies (ETOs) performed during revision THAs.

From 2003 to 2013, 612 ETOs were performed during revision THAs using 2 techniques. 367 were Paprosky type and 245 were Wagner type. Indications were aseptic loosening (65%), periprosthetic joint infection (18%), periprosthetic fracture (6%), femoral implant fracture (5%), and other (6%). Mean age 69 years, 58% male. Median follow-up 5 years (range, 2.1 to 13 years).

Mean Harris Hip Scores increased from 57 preoperatively to 77 at latest follow-up (p=0.0001). Radiographic union of the extended osteotomy occurred in 98%. There were 9 ETO nonunions. Mean time to union of the distal transverse osteotomy was 5.9 months (range, 1 month − 2 years). Mean trochanteric osteotomy fragment migration prior to union was 3 mm (range, 0–29 mm). Over 1 cm of migration occurred in 7.4%. Intraoperative fracture of the ETO diaphyseal fragment occurred in 4%, and postoperative greater trochanter fractures in 8.8%. Other complications: dislocation in 5.7% and infection in 3.4%. Dislocation occurred in 19 of 462 with ETO migration < 1 cm and 4 of 39 with ETO migration ≥1 cm (p=0.08). Ten year survivorship free of revision for aseptic femoral loosening, free of any component removal or revision, and free of reoperation were 97%, 91%, and 82%, respectively.

The union rate after ETO was high and notable trochanteric migration was infrequent. The most common complication was fracture intraoperatively or postoperatively of the osteotomy fragment.

115 patients undergoing primary unilateral THA were randomized to either DAA or MPA. Groups did not differ in mean age, sex, or mean body mass index. Functional results included time to discontinue gait aids, discontinue all narcotics, and independence with various activities of daily living. Activity in study subjects was measured with 5 wearable activity monitoring sensors with tri-axial MEMS accelerometers and validated custom algorithms and conducted over three days at pre-op, 2 weeks, 8 weeks, and one year. SF-12, WOMAC, and HHS scores to one year were also tabulated.

Early functional recovery slightly favoured DAA compared to MPA; time to discontinue walker (10 vs. 14.5 days), time to discontinue all gait aids (17.3 vs 23.6 days), ascend stairs with gait aid (5.4 vs. 10.3 days), and to walk 6 blocks (20.5 vs. 26.0 days). There were no other differences in early functional milestones. Activity monitoring at two weeks postoperatively slightly favoured DAA; mean steps per day were 3897 versus MPA 2,235, percent of day active, DAA 10.5% versus MPA 6.9%. There was no difference in activity monitoring pre-operatively, at two months, or at one year. There was no difference at one year with the SF-12. There was no difference in the SF-12 mental component or the HOOS at any time point. There was no loosening or subsidence of any of the components in any hip.

Both the direct anterior and posterior approach provided excellent early postoperative recovery with a low complication rate. The direct anterior patients had slightly faster recovery than the mini-posterior approach patients, with slightly shorter times to achieve milestones of function and as measured by advanced, quantitative activity monitoring at 2 weeks postoperatively.